MMRC Horizon One: RRMM (MMRC-099)

Clinical trial NCT06171685 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06171685
Sponsor: Multiple Myeloma Research Consortium
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapse Multiple Myeloma Refractory Multiple Myeloma

Start date: 2024-11-17
Primary completion: 2029-07-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.